Force Testing of Explanted Magnetically Controlled Growing Rods by Rushton PRP et al.
Force testing explanted MAGEC rods 
	   1	  
Force testing of explanted magnetically controlled growing rods 
 
Rushton PRP, Smith SL*, Forbes L*, Bowey AJ, Gibson MJ, Joyce TJ* 
 
 
Great North Children’s Hospital, Royal Victoria Infirmary, Newcastle upon 
Tyne, NE1 4LP, UK 
*School of Engineering, Newcastle University, Newcastle upon Tyne, NE1 
7RU, UK 
 
Acknowledgements 
The authors wish to thank the surgeons contributing cases to this study from 
Birmingham, Bristol, Exeter, Leeds, Oxford and Sheffield in the UK and 
Aarhus in Denmark. We thank the manufacturers of the implant, Nuvasive 
Specialised Orthopaedics, San Diago, US, who kindly provided a testing jig 
and two unused rods, but did not influence the conduct of this independent 
study. 
 
  
Force testing explanted MAGEC rods 
	   2	  
ABSTRACT  
 
Study Design:  
Laboratory analysis of explanted MAGnetic Expansion Control (MAGEC) growing 
rods  
 
Objective: 
Measure the force produced by explanted MAGEC rods compared with new rods and 
assess the influence of clinical variables. 
 
Summary of background data: 
MAGEC rods are increasingly used in early onset scoliosis. Some data is available 
describing the structure of explanted MAGEC rods but to date no study has 
assessed their function. 
 
Methods: 
Explanted MAGEC rods were received from seven UK and one Danish centre. The 
force produced by explanted rods on activation with the external remote controller 
was measured using a dedicated jig. Forces were compared to two unused rods as 
well as the manufacturer’s defined standard (42 Ibf). Clinical variables were collected 
from contributing centres where possible and correlated with the force 
measurements. 
 
Results: 
Forty-five MAGEC rods from 25 cases were received for analysis. The mean age at 
insertion was 8.6 years and rods were in vivo for a mean of 2.7 years in 
predominantly dual rod constructs. 
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Two unused MAGEC rods produced a mean force of 45.3 (0.25) and 50.2 (1.4) Ibf, 
above the manufacturer’s stated standard. 
Of the 45 explanted rods 10 (22%) produced force greater or equal to manufacturer’s 
standard, mean 46.7 (2.7) Ibf. Six rods (13%) produced some force but less than the 
manufacturer’s standard, mean 34.8 (3.6) Ibf. Twenty-nine rods (64%) produced no 
force. The duration the rods were in vivo was significantly negatively correlated with 
the force produced on testing (r=-0.63, P<0.005). Of the 12 rods implanted longer 
than 38 months none produced any force. 
 
Conclusions: 
This is the first study of the force, and hence likely function, of explanted MAGEC 
rods. The majority of explanted rods produced no force whilst others produced 
reduced force. These findings raise questions regarding the longevity of the implant 
and further clinical outcome studies are recommended. 
 
Level of Evidence: 4 
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INTRODUCTION 
 
 The MAGnetic Expansion Control (MAGEC) system has been used 
increasingly in recent years for the management of early onset scoliosis.  The system 
has been available for use in the UK and Europe since 2009 and has recently been 
approved for use in the US by the FDA. The MAGEC system includes a magnetically 
controlled linear actuator to allow non invasive lengthening. This aims to avoid the 
repeated surgeries of traditional distraction growing rod treatment, a great advantage 
to patients and surgeons. The system is relatively new, with only limited short-
medium term data available in the literature to date. Reports from the literature are 
mixed and whilst some good outcomes have been reported concerns have been 
raised regarding failure of the lengthening mechanism and tissue metallosis. 1-12  
 Work to date analysing explanted MAGEC rods has identified excessive wear 
within the actuator. Joyce et al. proposed a mechanism of offset loading leading to 
wear debris production, which when associated with failure of the actuator’s seal, 
may result in the tissue metallosis seen in some clinical studies as well as potential 
systematic spread.6,7,11,13 This and other available analyses have considered only the 
structure of explanted MAGEC rods with no data currently available regarding the 
function of explanted rods.14 Unlike many orthopaedic implants MAGEC rods are 
designed to be removed in all cases not simply from failed cases. Furthermore rods 
may be removed in settings when the lengthening mechanism would be likely 
functional, such as following anchor failure or following full lengthening of the implant. 
Hence a study of function of explanted MAGEC rods is of clinical relevance to 
surgeons. In this study we aim to assess what proportion of MAGEC rods are still 
able to produce force after explantation and if so assess how the force compares to 
before implantation. Clinical variables will be examined to assess their influence on 
the force produced.  
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MATERIALS AND METHODS 
 
Explanted MAGEC rods were received from seven spinal surgical centres in 
England and one in Denmark as part of an ongoing retrieval study by Newcastle 
University and the Great North Children’s Hospital, both in Newcastle upon Tyne, 
UK. 
Following explantation for any clinical reason rods were transferred to the 
School of Engineering, Newcastle University for analysis. Clinical data for the cases 
including baseline demographic data, underlying diagnosis, height and weight, dates 
of MAGEC rod insertion and removal, construct design and reason for removal was 
requested from contributing centres.  
The manufacturers of the MAGEC system (Nuvasive Speciliased 
Orthopaedics, San Diago, US) kindly provided a bespoke force testing jig including a 
digital force gauge (Chatillon DFE2-500, AMETEK, Largo, US). Rods were tested 
according to a protocol supplied by the manufacturer which is used to test rods 
before distribution. This involved retracting the extending rod of the MAGEC rod fully 
using a handheld external magnet. On the occasions this was insufficient to ‘free up’ 
the rod an external remote controller (ERC) was used to partially retract the 
extending rod. Rods were then trimmed or straightened to allow seating in the testing 
jig. A small preload (approximately 5 Ibf) was applied to the MAGEC rod. An ERC 
was positioned to overlie the magnet portion of the MAGEC rod and used to extend 
against the force gauge. The ERC was applied until ‘clunking’ of the MAGEC rod was 
heard and the reading on the force gauge was then recorded. Measurements were 
repeated three times per rod and the mean force calculated. Explanted rods as well 
as two unused MAGEC rods provided by the manufacturer were assessed and 
compared to the manufacturer’s stated standard for a functional rod of 42 Ibf 
(perscom). The experimental setup is shown in Figure 1. 
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Analysis was performed to assess for influences on the force produced by the 
rods on testing. Bivariate analysis using Pearson’s correlation coefficient between 
force output and suitable continuous variables [patient age/mass/height at MAGEC 
insertion, time rod(s) in vivo and mass/height at time removal] was performed. 
Categorical variables were compared using student t test or ANOVA with Tukey post 
hoc analysis for >2 groups. All statistical analysis was performed with SPSS v22 
(IBM-SPSS, Armonk, New York) with a p<0.05 was considered significant.  
 
 
RESULTS 
 
 Forty-five explanted MAGEC rods were received from 25 patients.  Forty-two 
rods were ‘modification 2’ type and 3 were the older ‘modification 1’. Available clinical 
data is detailed in Table 1.  
The two unused MAGEC rods produced a mean force of 45.3 (0.25) and 50.2 
(1.4) Ibf. These are above the manufacturer’s stated standard of 42 lbf for a 
functional rod. 
Of the 45 explanted rods 10 (22%) produced force greater or equal to 
manufacturer’s standard, mean 46.7 (2.7) Ibf. These were termed ‘full force’. Six rods 
(13%) produced some force but less than the manufacturers standard, mean 34.8 
(3.6) Ibf and were classed as ‘reduced force’. Twenty-nine rods (64%) produced ‘no 
force’.  Table 3 details the rods analysed for each case.   
The 10 ‘full force’ rods were explanted from 7 cases treated with dual rod 
constructs. Three cases had two ‘full force’ rods, 3 cases had one ‘full force’ rod with 
a contralateral ‘no force’ rod and one case had a ‘full force’ rod with a contralateral 
‘reduced force’ rod. The remaining 5 ‘reduced force’ rods were from a single rod 
construct, a hybrid construct (single concave MAGEC rod with convex sliding rod), a 
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dual rod construct with bilateral ‘reduced force’ rods and one dual rod case with a 
‘reduced force’ rod with a contralateral ‘no force’ rod. The other ‘no force’ rods were 
used in 11 dual rod constructs in which neither rod produced force and 3 single rod 
constructs. In summary the constructs from 3 of the 25 patients were able to 
lengthen at ‘full force’ whereas in 4 cases rods were able to lengthen but with at least 
one rod present in the construct at ‘reduced force’. Constructs from 18 cases 
contained rods producing ‘no force’. 
In terms of reasons for removal, 9 cases rods were removed for ‘failure to 
lengthen’ or ‘conversion to definitive fusion’. These are analysed together as the 
former commonly leads to the latter. This group included 5 bilateral constructs with 
neither rod producing any force and in 3 cases one rod produced ‘no force’ and the 
other rods produced ‘full force’. The remaining case was the hybrid construct where 
the single MAGEC rod had reduced force. Rods removed for anchor failure, infection, 
rod fracture or full lengthening achieved are grouped together as they were 
considered likely to function at removal. These 6 cases included 11 rods in which 3 
produced ‘full force’, 3 ‘reduced force’ and 5 ‘no force’.   
The duration the rods were in vivo was significantly negatively correlated with 
the force produced on testing (r=-0.63, P<0.005, Figure 2). Accordingly the length of 
time rods were implanted differed significantly between those with ‘full’ (16.8 (13.1) 
months) or ‘reduced force’ (21.3 (14.2) months) with those producing ‘no force’ (40.2 
(12.9) months), p=0.001 and p=0.03 respectively. Length of time implanted was 
similar between the ‘full’ and ‘reduced’ force groups (p=0.85). Of the 34 rods in which 
the duration of implantation was known, all 12 implanted for greater than 38 months 
produced ‘no force’. There were no significant correlations between force produced 
and the other continuous variables tested. 
The mean rod force between clinical groups is detailed in Table 2. There 
were no significant between group comparisons. 
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DISCUSSION 
 
This is the first study to examine the function of explanted MAGEC rods. 64% 
of explanted rods produced no force and only 22% of explanted rods produced a 
force greater or equal to the manufacturer’s stated standard. We accept that the very 
nature of explant analysis introduces a selection bias. Yet unlike explant analyses of 
most orthopaedic implants the MAGEC device is designed to be removed in all 
cases. So a proportion of rods could reasonably be expected still to be functional. It 
is notable that rods removed in clinical settings when the rod would be expected to 
be functional, including rod fracture or full lengthening achieved, commonly produced 
reduced or no force. 
 Given that the majority of rods implanted for a mean of 2.7 years were non 
functional and no rod implanted longer than 38 months was able to produce the 
manufacturer’s stated standard force our findings raise questions about the longevity 
and cost-effectiveness of the implant. Given the high cost of the initial and any 
replacement implants these findings are pertinent to the cost analyses that have 
influenced the implant’s adoption. The available cost analyses suggest a saving 
using the MAGEC system after 3-6 years. Rolton et al. suggested a cost saving 
using MAGEC rods after 5 years but do not appear to account for replacement of 
MAGEC rods during or at the end of this period.15 Su et al. from a US payer’s 
perspective identified a saving after 3 years with a MAGEC failure rate of 13% per 
year necessitating the change of a single rod. Polly et al. identified a cost saving after 
6 years from a US provider perspective assuming an annual failure rate of the 
MAGEC rods of 4.4% and rods being replaced routinely after 3.8 years, to allow for 
more growth.16  
There remains a paucity of literature assessing the outcomes of this 
treatment over the anticipated lifetime of the implant with most studies reporting 
outcomes at less than 3 years.1,6,17-19 The limited available longer term studies report 
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less favourable results.9 The present study is not a study of clinical outcomes. We 
have no estimation for the number of rods implanted over the course of the study 
period in the various centres. It is clear that the findings suggest further work must be 
undertaken urgently to assess the survivorship and costs associated with the 
MAGEC implant. 
Applying our laboratory study of explanted rods to assess whether the 
explanted constructs were likely functional at time of removal is not straightforward.  
Traditional growing rod (TGR) treatment typically aims to achieve the maximum 
lengthening with each open distraction. This has been shown to equal or exceed the 
child’s natural spinal growth over this time, potentially through stimulating growth 
plates via the Hueter-Volkmann law.20 To apply this distraction force the applied force 
must overcome the stiffness of the spine. Nordeen et al. identified that when using 
TGRs this force increased over the course of treatment, from 142N at the time of first 
distraction to 608N by the 10th lengthening.21 This likely results in the observed ‘law 
of diminishing returns’ regarding the lengthening achieved over time with TGRs.22 
The force a MAGEC rod must produce to distract the spine has not been identified. 
Specifically it is unknown if awake lengthenings, typical of MAGEC, require greater 
force to overcome greater soft tissue tension. Feasibly the MAGEC system in 
avoiding multiple surgical exposures may limit the stiffening of the spine over time 
seen with TGRs. Notwithstanding this it appears that, similar to TGRs, the 
lengthening achieved with MAGEC rods decreases over time.23 We have shown that 
at least in some cases this is likely multifactorial both relating to reduced force 
produced by the MAGEC rods as well as the presumed stiffening of the spine over 
time. In regard spinal stiffening it is noteworthy that the manufacturer’s force 
standard of 42 Ibf is approximately 187 N. This corresponds to the force required for 
no more than the first 3-4 lengthenings in work by Nordeen et al.21 Whilst many 
MAGEC users employ a similar philosophy to TGRs, as discussed, others propose 
‘following’ rather than ‘stimulating’ growth, aiming to lengthen according to the 
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normative data provided by Dimeglia and Canavese12,24,25 This technique will likely 
require less force from the MAGEC rods but again this value, to date, not been 
determined. Irrespective of the strategy used it is irrefutable that rods must actively 
lengthen to be functional. Using this measure, in 7 of the 25 cases all rods present in 
the construct were able to produce some force. Thus these may have been 
functional at the time of explantation. 
 It is apparent that after time in vivo a proportion of rods produce less force 
and others cease to produce any force. Currently the relationship between the force 
produced and the internal findings is not known. But considering these findings 
alongside the previous explant analysis by Joyce et al. excessive wear maybe one 
underlying cause. Feasibly wear debris within the casing increases the friction 
between the internal components limiting the force produced when activated by the 
ERC. Accordingly wear debris has been seen to foul bearings and ‘pack’ the 
potential space between the rotating magnet and leadscrew and inner aspect of the 
actuator casing.13 It is possible that the rods producing ‘no force’ may be associated 
with excessive wear debris limiting any rotation of the internal components. Drive pin 
fracture may have occurred in some cases. Further work is necessary to correlate 
force measurements and internal analysis of explanted MAGEC rods. 
 This study has several limitations. The testing rig used is dissimilar to the 
clinical environment. In vivo both the loading and extension of a rod are not linear as 
in this experiment, moreover rods are subject to offset loading due to the anteriorly 
placed centre of mass relative to the rods. This could lead to increased friction 
between actuator components limiting their free movement and force produced. 
Furthermore the ERC is positioned optimally to the actuator on the testing jig, 
maximizing magnetic field strength and presumably the torque imparted to the 
internal mechanism. It has been shown that an increased distance between actuator 
and ERC, caused by the soft tissues clinically, has a deleterious affect on 
lengthening.26 In summary whilst the testing environment is far from reproducing the 
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conditions in vivo it should be ideal for achieving the maximum force from the rods. 
Clinical data was unfortunately not available for a proportion of the rods analysed. It 
remains that further work is necessary to link explant analysis with clinical variables.  
Despite these limitations we feel the available data has allowed us to produce 
clinically meaningful results of use to deformity surgeons.  
 In summary this is the first study to assess the force produced by explanted 
MAGEC rods. We have identified, from a multicentre cohort, that the majority of 
explanted MAGEC rods are incapable of force production by the time of explantation. 
Less than a quarter of explanted rods were able to produce the force comparable to 
the manufacturer’s standard. These findings suggest caution in the use of the implant 
until long term clinical outcome studies are available to assess the survivorship and 
costs associated with its use. 
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Figure 1 – Photograph detailing the testing jig setup; MAGEC rod (centre) being 
tested on the force measurement jig.  To the top of the image the ERC can be seen, 
towards the bottom on the image is the force gauge (reading 23.4 lbf). Beneath the 
force gauge is the aluminium baseplate of the force jig. 
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Figure 2: Time explanted rods in vivo vs. force. Solid line; line of best fit for 
explanted rods. Dotted line; manufacturer’s standard 42Ibf. 
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Table 1: Baseline clinical data. Values given as mean (S.D) unless otherwise stated. 
 
Variable (number of cases available data)  
Sex 
(n=19) 
12 Female 
7 Male 
Age at insertion (n=19) 8.7 (2.6) 
Underlying aetiology 
(n=19) 
11 idiopathic 
6 syndromic 
2 congenital 
Mass at insertion (n=12) 25.8kg (7.7) 
Age at insertion (n=20) 8.7 years (2.6) 
Primary vs revision 
(n=17) 
12 primary 
5 revision 
Construct  
(n=25) 
20 dual rods 
4 single rod 
1 hybrid  
Number of lengthenings (n=12) 11.1 (4.9) 
Duration rods in vivo (n=20) 2.6 (1.4) years 
Reason for removal 
(n=15) 
6 failure of rods to lengthen 
3 conversion to definitive fusion 
2 rod fracture 
2 full lengthening achieved 
1 infection 
1 anchor failure 
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 Table 2: Rod force according to clinical variables.  
 
Variable (number rods) Force (Ibf) Between group 
comparisons 
Sex  Female (n=21) 18.1 (21.9) Between group 
comparisons ns Male (n=15) 14.9 (21.9) 
Unknown (n=9) 8.1 (16.2) 
Diagnosis Idiopathic (n=20) 12.4 (18.8) Between group 
comparisons ns Syndromic (n=9) 10.2 (20.3) 
Congenital (n=3) 40.5 (9.6) 
Unknown (n=13) 16.5 (22.1) 
Primary vs. 
revision 
Primary (n=22) 15.5 (21.3) Between group 
comparisons ns Revision (n=9) 13.3 (20.7) 
Unknown (n=14) 15.4 (21.6) 
Construct Single rod (n=4) 7.4 (14.9) Between group 
comparisons ns Dual rod (n=40) 15.3 (21.4) 
Hybrid (n=1) 32.0 (N/A) 
Reason for 
removal 
Rod fracture 
(n=3) 
22.5 (19.9) Between group 
comparisons ns 
Anchor failure 
(n=2) 
46.0 (3.2) 
Infection (n=2) 39.6 (5.2) 
Failure to 
lengthen (n=12) 
8.2 (19.3) 
Conversion to 
fusion (n=3) 
10.7 (18.5) 
Full lengthening 
achieved (n=4) 
0.0 (0.0) 
Unknown (n=19) 16.1 (21.9) 
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Table 3: Duration of implantation, reason for removal and force on testing for each 
case 
 
Case Rods Duration in vivo 
(month) 
Reason removal Mean 
Force 
(lbf) 
1 
1 
26.7 Anchor failure 43.7 
2 48.2 
2 3 34.8 Conversion to fusion 32.0 
3 
4 
1.2 Infection 43.2 
5 35.9 
4 
6 
37.3 Failure to lengthen 0.0 
7 0.0 
5 
8 
45.1 Conversion to fusion 0.0 
9 0.0 
6 
10 
25.7 Rod fracture 0.0 
11 37.9 
7 12 25.5 Rod fracture 29.7 
8 
13 
Unknown Unknown 
46.2 
14 47.6 
9 
15 
46.9 Unknown 0.0 
16 0.0 
10 
17 
56.9 Unknown 0.0 
18 0.0 
11 
19 
Unknown Unknown 0.0 
20 0.0 
12 
21 
7.8 Unknown 43.3 
22 48.4 
13 23 28.1 Unknown 0.0 
14 24 9.6 Unknown 0.0 
15 
25 
48.2 Full length achieved 
0.0 
26 0.0 
16 
27 
37.7 Failure to lengthen 
47.0 
28 0.0 
17 
29 
35.4 Failure to lengthen 
0.0 
30 0.0 
18 31 Unknown Unknown 34.1 32 39.3 
19 
33 
51.7 Failure to lengthen 
0.0 
34 0.0 
20 35 Unknown Unknown 0.0 
21 
36 
Unknown Unknown 
0.0 
37 0.0 
22 
38 
55.4 Failure to lengthen 
0.0 
39 0.0 
23 40 Unknown Conversion to fusion 47.8 
Force testing explanted MAGEC rods 
	   18	  
41 0.0 
24 
42 
14.5 Failure to lengthen 
0.0 
43 51.8 
25 
44 
33.2 Full length achieved 
0.0 
45 0.0 
 
 
